Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action.
about
Repurposing psychiatric medicines to target activated microglia in anxious mild cognitive impairment and early Parkinson's diseaseProphylactic and therapeutic functions of drug combinations against noise-induced hearing lossMemantine protects rats treated with intrathecal methotrexate from developing spatial memory deficits.Targeting ligand-operated chaperone sigma-1 receptors in the treatment of neuropsychiatric disorders.Involvement of sigma-1 receptors in the antidepressant-like effects of dextromethorphan.Inhibition of 3,4-methylenedioxymethamphetamine metabolism leads to marked decrease in 3,4-dihydroxymethamphetamine formation but no change in serotonin neurotoxicity: implications for mechanisms of neurotoxicityLow dose dextromethorphan attenuates moderate experimental autoimmune encephalomyelitis by inhibiting NOX2 and reducing peripheral immune cells infiltration in the spinal cordSinomenine protects against ischaemic brain injury: involvement of co-inhibition of acid-sensing ion channel 1a and L-type calcium channels.Evaluation of the neuroprotective effect of dextromethorphan in the acute phase of ischaemic strokeCharacterization of pulmonary sigma receptors by radioligand bindingEffects of dextromethorphan and oxycodone on treatment of neuropathic pain in mice.Dual Therapeutic Effects of C-10068, a Dextromethorphan Derivative, Against Post-Traumatic Nonconvulsive Seizures and Neuroinflammation in a Rat Model of Penetrating Ballistic-Like Brain Injury.The sigma-1 receptor: roles in neuronal plasticity and diseaseDextromethorphan/quinidine: in pseudobulbar affect.Therapeutic Approach of a High Functioning Individual With Traumatic Brain Injury and Subsequent Emotional Volatility With Features of Pathological Laughter and Crying With Dextromethorphan/Quinidine.Intravenous dextromethorphan/quinidine inhibits activity of dura-sensitive spinal trigeminal neurons in rats.Effects of dextromethorphan on glial cell function: proliferation, maturation, and protection from cytotoxic molecules.Repeated, high-dose dextromethorphan treatment decreases neurogenesis and results in depression-like behavior in rats.Prevention of Hippocampal Neuronal Damage and Cognitive Function Deficits in Vascular Dementia by Dextromethorphan.Methotrexate-induced posterior reversible encephalopathy syndrome.Modifying chemotherapeutic management of a patient with Burkitt's lymphoma and pre-existing motor neurone disease.Dextromethorphan and quinidine are suitable for off-label short-term treatment of agitation in people with Alzheimer's disease following first-line non-drug approaches.
P2860
Q26748711-F756CADD-4240-4CF0-B091-9964B9DB3C2FQ28388403-7E9FE3EE-2F1A-41DE-9014-DE89469806C4Q34213155-9D95B5C9-7875-4E72-91D6-C2951B362306Q34795242-742EB72E-DE0B-4C4D-A114-4D1F6AAF106EQ35108500-CF107DFB-4199-4DFF-8723-E2416A7A06F4Q35109208-8B809839-2196-4D05-9590-30B1AFA299AAQ35156771-CBD00B4B-5BF6-47CE-9C6F-EE0458E91ABEQ35564271-79DF5018-A84E-4413-9542-5D6B5E365DB8Q35674149-489B6915-BC5E-4E23-B286-FAC46950F73BQ35977409-092DAEF6-D6DF-4EE1-A891-8C42193EBDE6Q36081817-8A448F98-3BC3-489B-8AE7-2C79B9A85D89Q36123009-DA8B0852-A212-4EF0-BC78-A49828F953A7Q36653400-F0685BBC-268E-481A-8D37-5BF5ADDF8081Q37863094-FD3BEA7A-5EB7-424C-850B-E7A5210D2C4EQ41164001-CE80EC5D-652F-44D7-9191-B65A786F7B59Q46550880-7C9C38C0-D8CA-4988-8DDC-ECD210ABD1E0Q46932015-C9CD5A25-3918-4CBB-94F6-6026A766D68CQ47654849-350D4C5F-227C-48E4-AA59-54FD784209A0Q48898933-03C642F5-78B1-4D3F-B6F3-0428C9E21EA9Q51820441-E1D8FDD5-D4E2-490C-9412-A1BB8D45268FQ53003439-7A1CF20E-290B-4625-A350-A0DADE62F8E0Q53484460-7665448F-89CD-4675-BB24-69B45F2F267E
P2860
Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action.
@en
type
label
Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action.
@en
prefLabel
Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action.
@en
P2093
P1433
P1476
Dextromethorphan as a potential neuroprotective agent with unique mechanisms of action.
@en
P2093
Edward C Lauterbach
Linda L Werling
Ursula Calef
P304
P356
10.1097/NRL.0B013E3180F60BD8
P407
P577
2007-09-01T00:00:00Z